References

Beta Switch Program

Beta Switch Program by Sue Heintze

Get Instant Access

1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932;50:137-195.

2. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994;41(3):359-364.

3. Aron DC, Findling JW, Tyrrell JB. Cushing's disease. Endocrinol Metab Clin North Am 1987;16(3):705-730.

4. Mampalam TJ, Tyrrell JB, Wilson, CB. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 1988;109(6):487-493.

5. Carey RM, et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N Engl J Med 1984;311(1):13-20.

6. Auchus RJ, et al. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome. J Endocrinol Invest 1994;17(6):447-452.

7. Newell-Price J, et al. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19(5):647-672.

8. Yanovski JA, Cutler GB, Jr. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994;23(3):487-509.

9. Magiakou MA, et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994;331(10):629-636.

10. Magiakou MA, Mastorakos G, Chrousos GP. Final stature in patients with endogenous Cushing's syndrome. J Clin Endocrinol Metab 1994;79(4):1082-1085.

11. Robyn JA, et al. Cushing's syndrome in childhood and adolescence. J Pediatr Child Health 1997;33(6):522-527.

12. Savage MO, et al. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 2001;55(Suppl 1):24-30.

13. Koch CA, et al. Spinal epidural lipomatosis in a patient with the ectopic corticotropin syndrome. N Engl J Med 1999;341(18):1399-400.

14. Orth DN, Cushing's syndrome. N Engl J Med 1995;332(12):791-803.

15. Koch CA, et al. Cushing's disease presenting with avascular necrosis of the hip: an orthopedic emergency. J Clin Endocrinol Metab 1999;84(9):3010-3012.

16. Bouzas EA, et al. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation. Invest Ophthalmol Vis Sci 1993;34(13):3497-3500.

17. Dorn LD, et al. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997;82(3):912-919.

18. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57(10):925-935.

19. Starkman MN. et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32(9):756-765.

20. Bailey RE. Periodic hormonogenesis—a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 1971;32(3):317-327.

21. Atkinson AB, et al. Five cases of cyclical Cushing's syndrome. Br Med J (Clin Res Ed) 1985;291(6507):1453-1457.

22. Brown RD, et al. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 1973;36(3):445-451.

23. Hocher B, et al. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. Acta Endocrinol (Copenh) 1993;128(2):120-125.

24. Liebowitz G, et al. Fluctuating hyper-hypocortisolaemia: a variant of Cushing's syndrome. Clin Endocrinol (Oxf) 1997;46(6):759-763.

25. Oates TW, et al. Cushing's disease with cyclic hormonogenesis and diabetes insipidus. Neurosurgery 1979;5(5):598-603.

26. Atkinson AB, et al. Cyclical Cushing's disease: two distinct rhythms in a patient with a basophil adenoma. J Clin Endocrinol Metab 1985;60(2):328-332.

27. Liberman B, et al. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis. J Clin Endocrinol Metab 1976;43(4): 913-918.

28. Mosnier-Pudar H, et al. Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary Cortisol measurements. Eur J Endocrinol 1995;133(3): 313-316.

29. Vagnucci AH, Evans E. Cushing's disease with intermittent hypercortisolism. Am J Med 1986;80(1):83-88.

30. Sakiyama R., Ashcraft MW, Van Herle AJ. Cyclic Cushing's syndrome. Am J Med 1984; 77(5):944-946.

31. Carson DJ, et al. Cyclical Cushing's syndrome presenting as short stature in a boy with recurrent atrial myxomas and freckled skin pigmentation. Clin Endocrinol (Oxf), 1988;28(2):173-180.

32. Koch CA, et al. (Primary pigmented nodular adrenocortical dysplasia (PPNAD) within the scope of Carney complex as the etiology of Cushing syndrome). Med Klin 2000;95(4):224-230.

33. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000; 29(1):43-56.

34. Krieger DT. Physiopathology of Cushing's disease. Endocr Rev 1983;4(1):22-43.

35. Biller BM. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic. Endocrinol Metab Clin North Am 1994;23(3):547-554.

36. Gertz BJ, et al. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 1987;120(1):381-388.

37. Schnall AM, et al. Pituitary Cushing's disease without adenoma. Acta Endocrinol (Copenh) 1980;94(3):297-303.

38. Horvath E, Kovacs K, Scheithauer BW. Pituitary hyperplasia. Pituitary 1999;1(3-4):169-179.

39. Saeger W, Ludecke DK. Pituitary hyperplasia. Definition, light and electron microscopical structures and significance in surgical specimens. Virchows Arch 1983;399(3):277-287.

40. Scheithauer BW, et al. Pituitary carcinoma: an ultrastructural study of eleven cases. Ultrastruct Pathol 2001;25(3):227-242.

41. Ratliff JK, Oldfield EH. Multiple pituitary adenomas in Cushing's disease. J Neurosurg 2000;93(5):753-761.

42. Stenzel-Poore MP, et al. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 1992;130(6):3378-3386.

43. Dahia PL, Grossman AB. The molecular pathogenesis of corticotroph tumors. Endocr Rev 1999;20(2):136-155.

44. Schulte HM, et al. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 1991;73(6):1302-1308.

45. Biller BM, et al. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab 1992;75(5):1303-1309.

46. Shimon I, Melmed S. Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab 1997;82(6):1675-1681.

47. Gicquel C, et al. Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab 1992;75(2):472-475.

48. Herman V, et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71(6):1427-1433.

49. Buckley N, et al. p53 Protein accumulates in Cushings adenomas and invasive non- functional adenomas. J Clin Endocrinol Metab 1994;79(5):1513-1516.

50. Karl M, et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 1996;108(4):296-307.

51. Karl M, et al. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab 1996;81(1):124-129.

52. Contreras LN, Hane S, Tyrrell JB. Urinary Cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations. J Clin Endocrinol Metab 1986;62(5):965-969.

53. Gomez MT, et al. Urinary free Cortisol values in normal children and adolescents. J Pediatr 1991;118(2):256-258.

54. Pavlatos FC, Smilo RP, Forsham PH. A rapid screening test for Cushing's syndrome. JAMA 1965;193:96-99.

55. Tsigos C, Papanicolaou DA, Chrousos GP. Advances in the diagnosis and treatment of Cushing's syndrome. Baillieres Clin Endocrinol Metab 1995;9(2):315-336.

56. Newell-Price J, et al. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1995;43(5):545-550.

57. Liddle GW. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1960;20:1539-1561.

58. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998;83(8):2681-2686.

59. Papanicolaou DA, et al. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998;83(4): 1163-1167.

60. Tsigos C, Chrousos GP. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metab Clin North Am 1994;23(3):451-466.

61. Gold PW, et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 1986;314(21):1329-1335.

62. Yanovski JA, et al. Corticotropin-releasing hormone stimulation following low-dose dex-amethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. Jama 1993;269(17):2232-2238.

63. White A, Clark AJ. The cellular and molecular basis of the ectopic ACTH syndrome. Clin Endocrinol (Oxf) 1993;39(2):131-141.

64. Chrousos GP, et al. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 1984;310(10):622-626.

65. Nieman LK, et al. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1993;77(5):308-312.

66. Flack MR, et al. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 1992;116(3):211-217.

67. Tyrrell JB, et al. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Ann Intern Med 1986;104(2):180-186.

68. Dichek HL, et al. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1994;78(2): 418-422.

69. Biemond P, de Jong FH, Lamberts SW. Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test. Ann Intern Med 1990;112(10):738-742.

70. Avgerinos PC, et al. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. Ann Intern Med 1994;121(5):318-327.

71. Doppman JL, et al. Macronodular adrenal hyperplasia in Cushing disease. Radiology 1988;166(2):347-352.

72. Doppman JL, et al. Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 2000;216(3):797-802.

73. Buchfelder M, et al. The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease. AJNR Am J Neuroradiol 1993;14(5):1183-1190.

74. Hall WA, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120(10):817-820.

75. Doppman JL, et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 1988;12(5):728-735.

76. Oldfield EH, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991;325(13):897-905.

77. Doppman JL, Oldfield EH, Nieman LK. Bilateral sampling of the internal jugular vein to distinguish between mechanisms of adrenocorticotropic hormone-dependent Cushing syndrome. Ann Intern Med 1998;128(1):33-36.

78. Doppman JL, et al. The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing's disease. J Clin Endocrinol Metab 1999;84(2):533-540.

79. Miller DL. Neurologic complications of petrosal sinus sampling. Radiology 1992; 183(3):878.

80. Semple PL, Laws ER, Jr. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg 1999;91(2):175-179.

81. Mamelak AN, et al. Venous angiography is needed to interpret inferior petrosal sinus and cavernous sinus sampling data for lateralizing adrenocorticotropin- secreting adenomas. J Clin Endocrinol Metab 1996;81(2):475-481.

82. Graham KE, et al. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J Clin Endocrinol Metab 1999;84(5):1602-1610.

83. Sasaki A, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1987;64(2):224-229.

84. Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992;79(1):130-137.

85. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993;119(11):1113-1124.

86. Friedman TC, Chrousos GP. Transsphenoidal resection in Cushing's disease: definition of success. Clin Endocrinol (Oxf) 1993;39(6):701.

87. Wilson CB. A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg 1984;61(5):814-833.

88. Pluta RM, et al. Extrapituitary parasellar microadenoma in Cushing's disease. J Clin Endocrinol Metab 1999;84(8):2912-2923.

89. Watson JC, et al. Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg 1998;89(6):927-932.

90. Oldfield EH, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985; 312(2):100-103.

91. Ram Z, et al. Early repeat surgery for persistent Cushing's disease. J Neurosurg 1994;80(1):37-45.

92. Simmons NE, et al. Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001;95(1):1-8.

93. Chee GH, et al. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 2001;54(5):617-626.

94. Nishizawa S, et al. What can predict postoperative "endocrinological cure" in Cushing's disease? Neurosurgery 1999;45(2):39-44.

95. Avgerinos PC, et al. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. J Clin Endocrinol Metab 1987;65(5):906-913.

96. Losa M, et al. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease. Clin Endocrinol (Oxf) 2001;55(1):61-68.

97. Sheehan JM, et al. Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor. Neurosurgery 2000;47(1):33-36; discussion 37-39.

98. Nieman LK, et al. Prediction of long-term remission of Cushing's disease after successful transsphenoidal resection of ACTH-secreting tumor. In: Program & Abstracts of the Annual Meeting of the Endocrine Society. San Diego, CA:1999.

99. McCance DR, Besser M, Atkinson AB. Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf) 1996;44(1):1-6.

100. McCance DR, et al. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf) 1993;38(1):79-86.

101. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995;80(11):3114-3120.

102. Wilson CB. The long-term results following pituitary surgery for Cushing's disease and Nelson's syndrome. In: Secretory Tumors of the Pituitary Gland. Black PM, et al., eds. New York: Raven Press; 1984;287-294.

103. Sheehan JM, et al. Radiosurgery for Cushing's disease after failed transsphenoidal surgery. J Neurosurg 2000;93(5):738-742.

104. Olson BR, et al. Isolated hyponatremia after transsphenoidal pituitary surgery. J Clin Endocrinol Metab 1995;80(1):85-91.

105. Kjellberg RN, et al. Proton beam therapy of Cushing's disease and Nelson's syndrome. In: Secretory Tumors of the Pituitary Gland. Black BM, et al., eds. New York: Raven Press; 1984;294-307.

106. Howlett TA, et al. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up. Clin Endocrinol (Oxf) 1989;31(3):309-323.

107. Luton JP, et al. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases. N Engl J Med 1979;300(9):459-464.

108. Zeiger MA, et al. Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 1993;114(6):1138-1143.

109. Nagesser SK, et al. Long-term results of total adrenalectomy for Cushing's disease. World J Surg 2000;24(1):108-113.

110. Nelson DH, et al. ACTH-producing tumor of the pituitary gland. N Engl J Med 1958;259:161-164.

111. Nelson DH, Meakin JW, Thorn GW. ACTH-producing pituitary tumors following adrena-lectomy for Cushing's syndrome. Ann Intern Med 1960;52:560-569.

112. Rahn T, Thoren M, Werner S. Stereotactic radiosurgery in pituitary adenomas. In: Pituitary Adenomas: New Trends in Basic and Clinical Research. Faglia G, et al., eds. New York: Elsevier Science; 1991;303-312.

113. Ganz JC. Gamma knife treatment of pituitary adenomas. In: Pituitary Adenomas. Landolt AM, Vance ML, Reilly PL, eds. New York, NY: Churchill-Livingstone; 1996;461-474.

114. Izawa M, et al. Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 2000;93 (suppl 3):19-22.

115. Hoybye C, et al. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 2001;49(2):284-291;discussion 291-292.

116. Estrada J, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med 1997;336(3):172-177.

117. Littley MD, et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 1989;70(262):145-160.

118. Hughes MN, et al. Pituitary adenomas: long-term results for radiotherapy alone and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1993;27(5):1035-1043.

119. Snyder PJ, et al. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986;81(3):457-462.

120. Halberg FE, Sheline GE. Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am 1987;16(3):667-684.

121. Engelhardt D, Weber MM. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 1994;49(4-6):261-267.

122. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocr Rev 1993;14(4):443-458.

123. Verhelst JA, et al. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf) 1991;35(2):169-178.

124. Krakoff J, et al. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab 2001;86(9):4104-4108.

125. Jenkins PJ, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1995;80(1):165-171.

126. McCance DR, et al. Bilateral adrenalectomy: low mortality and morbidity in Cushing's disease. Clin Endocrinol (Oxf) 1993;39(3):315-321.

127. Bax TW, et al. Laparoscopic bilateral adrenalectomy following failed hypophysectomy. Surg Endosc 1996;10(12):1150-1153.

128. Doherty GM, et al. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome. Surgery 1990;108(6): 1085-1090.

129. Weinstein M, Tyrrell B, Newton TH. The sella turcica in Nelson's syndrome. Radiology 1976;118(2):363-365.

130. Kelly WF, et al. Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients. Q J Med 1983;52(206):224-231.

131. Kasperlik-Zaluska AA, et al. Nelson's syndrome: incidence and prognosis. Clin Endocrinol (Oxf) 1983;19(6):693-698.

132. Cohen KL, Noth RH, Pechinski T. Incidence of pituitary tumors following adrenalectomy. A long-term follow-up study of patients treated for Cushing's disease. Arch Intern Med 1978;138(4):575-579.

133. Kemink SA, et al. Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) 2001:54(1):45-52.

134. Kemink L, et al. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease. J Clin Endocrinol Metab 1994;79(3):887-889.

135. Thomas CG, Jr, et al. Nelson's syndrome after Cushing's disease in childhood: a continuing problem. Surgery 1984;96(6):1067-1077.

136. Moore TJ, et al. Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation. Ann Intern Med 1976;85(6):731-734.

137. Hamwi GJ, et al. Activation of testicular adrenal rest tissue by prolonged excessive ACTH production. J Clin Endocrinol Metab 1963;23:861-869.

138. Wislawski J, et al. Results of neurosurgical treatment by a transsphenoidal approach in 10 patients with Nelson's syndrome. J Neurosurg 1985;62(1):68-71.

139. Pivonello R., et al. Complete remission of Nelson's syndrome after 1-year treatment with cabergoline. J Endocrinol Invest 1999;22(11):860-865.

Was this article helpful?

0 0

Post a comment